Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Kangwei Pharmaceutical is a Chinese pharmaceutical company headquartered in Yuncheng, Shanxi Province, specializing in the development and manufacturing of chemical drugs and traditional Chinese medicines (TCM). The company operates modern, GMP-certified production facilities that produce a variety of dosage forms, including capsules, tablets, and granules. Its product portfolio primarily targets respiratory health, cardiovascular diseases, and infectious diseases, with flagship products such as Compound Paracetamol and Amantadine Hydrochloride Capsules. Shanxi Kangwei serves as a significant regional manufacturer, providing a wide range of essential generic medications to the Chinese domestic market. The company is recognized as a high-tech enterprise within the Shanxi provincial industrial landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Kangwei Pharmaceutical.